Pathology of Second-Generation Everolimus-Eluting Stents versus First-Generation Sirolimus- and Paclitaxel-Eluting Stents in Humans

BACKGROUND: Clinical trials have demonstrated that second-generation cobalt-chromium everolimus-eluting stent (CoCr-EES) is superior to first-generation paclitaxel-eluting stent (PES) and is non-inferior or superior to sirolimus-eluting stent (SES) in terms of safety and efficacy. It remains unclear...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Otsuka, Fumiyuki, Vorpahl, Marc, Nakano, Masataka, Foerst, Jason, Newell, John B., Sakakura, Kenichi, Kutys, Robert, Ladich, Elena, Finn, Aloke V., Kolodgie, Frank D., Virmani, Renu
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915802/
https://ncbi.nlm.nih.gov/pubmed/24163064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.113.001790
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars